Akebia Therapeutics | AKBA - سود قبل از مالیات





سود قبل از مالیات تغییر دادن تاریخ
Acadia Pharmaceuticals USD 26.32M 18.28M 2025-12
Agios Pharmaceuticals USD -109.06M 5.62M 2025-12
Akebia Therapeutics USD -11.24M 12.39M 2025-12
Alnylam Pharmaceuticals USD 161.14M 77.83M 2025-12
Amgen USD 3.92B 2.35B 2025-09
Ardelyx USD -400K 467K 2025-12
Astellas Pharma JPY 133.96B 29.77B 2025-12
AstraZeneca USD 3.24B 117M 2025-09
Bayer EUR -1.16B 735M 2025-09
BioMarin Pharmaceutical USD -26.32M 324.19M 2025-09
Celltrion KRW 14.6B 180.89B 2025-06
Cspc Pharmaceutical CNY 1.21B 110.04M 2025-09
Dianthus Therapeutics USD -64.43M 27.67M 2025-12
Exelixis USD 252.69M 275K 2025-12
Fresenius Medical Care EUR 508.46M 105.89M 2025-12
GlaxoSmithKline GBP 1.23B 1.23B 2025-12
Ionis Pharmaceuticals USD -228M 99M 2025-12
Ironwood Pharmaceuticals USD 68.02M 30.2M 2025-09
J&J USD 4.97B 2.53B 2025-12
Kangmei Pharma CNY 2.07M 13.77M 2025-09
Karyopharm Therapeutics USD -30.89M 1.16M 2024-12
Knight Therapeutics CAD -1.92M 13.69M 2025-09
Laboratorios Farma EUR 26.78M 94.77M 2025-06
Lexicon Pharmaceuticals USD -12.77M 16.02M 2025-09
Medical Developments International AUD -149K 466K 2025-06
Moderna USD -187M 631M 2025-09
Nektar Therapeutics USD -37.05M 15.27M 2024-09
Neuren Pharmaceuticals AUD 9.86M 161.24M 2025-06
Organigram Holdings CAD -41.72M 25.52M 2025-09
Pharma Mar EUR 40.2M 44.28M 2025-12
Prothena USD -21.58M 15.33M 2025-12
PTC Therapeutics USD -139.08M 116.01M 2025-12
Qiagen NV USD 134.73M 7.91M 2025-09
Regeneron Pharmaceuticals USD 1.76B 244.6M 2025-09
Roche Holding CHF 4.79B 3.01B 2025-06
Sanofi EUR -1.16B 5.5B 2025-12
Sarepta Therapeutics USD -407.67M 213.63M 2025-12
Sartorius EUR 85M 14.1M 2025-09
Tectonic Therapeutic USD -18.97M 63K 2025-12
Tilray USD -39.96M 39.19M 2025-09
Vanda Pharmaceuticals USD -22.92M 16.68M 2024-12
Zealand Pharma A/S -406.5M 39.77M 2025-12
Zz Pientze Pharmaceu CNY 523.11M 659.54M 2025-06